.Attribute Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for introduction of people with MASLD and also size of liver results in cardio-- renal-- metabolic tests, when information propose mechanistically probable perks and also scientific safety-- and outlines points to consider for test layout as well as regulative approval.